CERo Therapeutics Holdings, Inc.
CERO
$9.46
$0.232.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.11M | -8.30M | -10.24M | -7.51M | -7.15M |
| Total Depreciation and Amortization | 1.14M | 1.16M | 1.16M | 1.15M | 1.13M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.99M | -7.61M | -3.73M | -4.12M | -2.39M |
| Change in Net Operating Assets | 2.67M | 1.84M | 468.60K | -416.60K | -1.03M |
| Cash from Operations | -12.28M | -12.92M | -12.34M | -10.90M | -9.43M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -13.82M | -8.13M | -7.84M |
| Total Debt Issued | 13.70K | 421.80K | 408.10K | 408.10K | 1.01M |
| Total Debt Repaid | -402.50K | -422.20K | -278.70K | -169.00K | -19.70K |
| Issuance of Common Stock | 12.01M | 12.07M | 12.07M | 9.50M | 6.77M |
| Repurchase of Common Stock | -500.80K | -500.80K | -- | -1.90K | -1.90K |
| Issuance of Preferred Stock | 2.34M | 2.74M | 2.74M | 2.00K | -- |
| Repurchase of Preferred Stock | -45.90K | -45.90K | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -528.20K | -528.20K | -2.69M | 13.70K | -41.20K |
| Cash from Financing | 12.89M | 13.73M | 12.24M | 9.75M | 7.72M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 610.50K | 811.70K | -96.00K | -1.15M | -1.71M |